Literature DB >> 20956606

In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods.

Thean Yen Tan1, Tze Peng Lim, Winnie Hui Ling Lee, Suranthran Sasikala, Li Yang Hsu, Andrea Lay-Hoon Kwa.   

Abstract

This study examined the in vitro effects of polymyxin B, tigecycline, and rifampin combinations on 16 isolates of extensively drug-resistant Acinetobacter baumannii, including four polymyxin-resistant strains. In vitro synergy was demonstrated in 19 (40%) of a possible 48 isolate-antibiotic combinations by time-kill methods, 8 (17%) by checkerboard methods, and only 1 (2%) by Etest methods. There was only slight agreement between Etest and checkerboard methods and no agreement between results obtained by other methods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956606      PMCID: PMC3019682          DOI: 10.1128/AAC.00850-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.

Authors:  C R Bonapace; R L White; L V Friedrich; J A Bosso
Journal:  Diagn Microbiol Infect Dis       Date:  2000-09       Impact factor: 2.803

2.  Synergy, antagonism, and what the chequerboard puts between them.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

3.  Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline.

Authors:  F S Taccone; H Rodriguez-Villalobos; D De Backer; V De Moor; J Deviere; J-L Vincent; F Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

4.  Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.

Authors:  Matthew E Falagas; Drosos E Karageorgopoulos
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

5.  Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.

Authors:  R L White; D S Burgess; M Manduru; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.

Authors:  Keith A Rodvold; Mark H Gotfried; Michael Cwik; Joan M Korth-Bradley; Gary Dukart; Evelyn J Ellis-Grosse
Journal:  J Antimicrob Chemother       Date:  2006-09-29       Impact factor: 5.790

7.  Use of different PCR-based DNA fingerprinting techniques and pulsed-field gel electrophoresis to investigate the epidemiology of Acinetobacter calcoaceticus-Acinetobacter baumannii complex.

Authors:  P Y Liu; W L Wu
Journal:  Diagn Microbiol Infect Dis       Date:  1997-09       Impact factor: 2.803

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.

Authors:  Tze-Peng Lim; Thean-Yen Tan; Winnie Lee; Suranthran Sasikala; Thuan-Tong Tan; Li-Yang Hsu; Andrea L Kwa
Journal:  J Antibiot (Tokyo)       Date:  2009-10-30       Impact factor: 2.649

10.  Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.

Authors:  María E Pachón-Ibáñez; Fernando Docobo-Pérez; Rafael López-Rojas; Juan Domínguez-Herrera; Manuel E Jiménez-Mejias; Andrés García-Curiel; Cristina Pichardo; Luis Jiménez; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

View more
  13 in total

Review 1.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

2.  Correlation of Checkerboard Synergy Testing with Time-Kill Analysis and Clinical Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Respiratory Infections.

Authors:  Derek N Bremmer; Karri A Bauer; Stephanie M Pouch; Keelie Thomas; Debra Smith; Debra A Goff; Preeti Pancholi; Joan-Miquel Balada-Llasat
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 3.  In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations.

Authors:  Stamatis Karakonstantis; Petros Ioannou; Diamantis D Kofteridis
Journal:  Infection       Date:  2022-01-04       Impact factor: 3.553

4.  The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence.

Authors:  Wenrui Gu; Dongmei Guo; Liuping Zhang; Dongmei Xu; Shujuan Sun
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.

Authors:  Mao Hagihara; Seth T Housman; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

6.  Antibiotic Resistance Profiles and Genotypes of Acinetobacter baumannii Isolates and In Vitro Interactions of Various Antibiotics in Combination with Tigecycline and Colistin.

Authors:  Ayça Büyük; Fethiye Ferda Yilmaz; Süreyya Gül Yurtsever; Mine Hoşgör Limoncu
Journal:  Turk J Pharm Sci       Date:  2017-04-15

7.  In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.

Authors:  Vien Le Minh; Nguyen Thi Khanh Nhu; Voong Vinh Phat; Corinne Thompson; Nguyen Phu Huong Lan; Tran Vu Thieu Nga; Pham Thi Thanh Tam; Ha Thanh Tuyen; Tran Do Hoang Nhu; Nguyen Van Hao; Huynh Thi Loan; Lam Minh Yen; Christopher M Parry; Ho Dang Trung Nghia; James I Campbell; Tran Tinh Hien; Louise Thwaites; Guy Thwaites; Nguyen Van Vinh Chau; Stephen Baker
Journal:  J Med Microbiol       Date:  2015-07-17       Impact factor: 2.472

8.  Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program.

Authors:  Shu-Chen Kuo; Shan-Chwen Chang; Hui-Ying Wang; Jui-Fen Lai; Pei-Chen Chen; Yih-Ru Shiau; I-Wen Huang; Tsai-Ling Yang Lauderdale
Journal:  BMC Infect Dis       Date:  2012-08-28       Impact factor: 3.090

9.  Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).

Authors:  Guangtao Huang; Xiaodong Shen; Yali Gong; Zhiwei Dong; Xia Zhao; Wei Shen; Jing Wang; Fuquan Hu; Yizhi Peng
Journal:  BMC Infect Dis       Date:  2014-12-12       Impact factor: 3.090

10.  In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.

Authors:  Gyun Cheol Park; Ji Ae Choi; Sook Jin Jang; Seok Hoon Jeong; Choon-Mee Kim; In Sun Choi; Seong Ho Kang; Geon Park; Dae Soo Moon
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.